FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Device Cybersecurity Quality System Consideration Guide

[ Price : $8.95]

FDA posts a final guidance entitled Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submi...

FDA RMAT Designation for Detalimogene

[ Price : $8.95]

FDA grants regenerative medicine advanced therapy designation for enGene Holdings bladder cancer drug detalimogene.

Viatris Plans NDA for MR-141 in Presbyopia

[ Price : $8.95]

Viatris plans to submit an NDA later this year for phentolamine ophthalmic solution 0.75% for treating presbyopia based on just-re...

Sterling Drug Supply Chain Violations

[ Price : $8.95]

FDA warns Sterling Distributors about its multiple violations of the Drug Supply Chain Security Act.

Guide on Developing Drugs for Lyme Disease

[ Price : $8.95]

FDA posts a final guidance entitled Early Lyme Disease as Manifested by Erythema Migrans: Developing Drugs for Treatment.

Lillys Amyvid Gets Updated Label

[ Price : $8.95]

FDA approves an updated label for Eli Lillys Amyvid (florbetapir F 18 injection) for brain imaging to estimate amyloid plaque dens...

FDA Approves New Warnings on Covid mRNA Vaccines

[ Price : $8.95]

FDA requires and approves updates to the prescribing information for Pfizers Comirnaty Covid-19 mRNA vaccine and Modernas Spikevax...

Stop FDAs Sudden Biosecurity Overreach: Newsletter

[ Price : $8.95]

A Global Biodefense online post says FDAs sudden decision to halt clinical trials that send samples overseas for processing can hu...

Syndax Gets Priority Review for Revuforj sNDA

[ Price : $8.95]

FDA grants Syndax Pharmaceuticals a priority review of its supplemental NDA for Revuforj (revumenib) as a treatment for relapsed o...

Reverse FDA Restructuring: Former GOP Representative

[ Price : $8.95]

Former GOP Rep. John Doolittle calls for immediate steps to reverse some of the FDA restructuring that he says will hurt regulated...